IP Library Granted Patent US 8,718,756
Granted Patent B2
US 8,718,756 · App. 12/851,761 · Granted May 6, 2014

Optimizing characteristics of an electric field to increase the field's effect on proliferating cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,718,756
App. No.
12/851,761
Granted
May 6, 2014
Kind
B2
Abstract

AC electric fields at particular frequencies and field strengths have been shown to be effective for destroying rapidly proliferating cells such as cancer cells. The effectiveness of such fields is improved when the field is sequentially switched between two or more different directions. The effectiveness of such fields can be improved even further by choosing the rate at which the field is switched between the various directions.

Claims (17)

1. An apparatus for applying a therapeutic electric field to a target region, the apparatus comprising:

a first pair of insulated electrodes, each electrode having a conductor and a surface configured for placement against a patient's body that is insulated from the conductor;

a second pair of insulated electrodes, each electrode having a conductor and a surface configured for placement against a patient's body that is insulated from the conductor;

a signal generator that generates a periodic control signal with first and second output states, the first and second output states each having a duration between 20 and 500 ms;

an AC signal generator that generates a first AC signal across the conductors of the first pair of electrodes when the control signal is in the first output state and generates a second AC signal across the conductors of the second pair of electrodes when the control signal is in the second output state, the first and second AC signals having a frequency between 50 and 500 kHz.

2. The apparatus of claim 1 , wherein the duration of the first output state is between 50 and 250 ms, and the duration of the second output state is between 50 and 250 ms.

3. The apparatus of claim 2 , wherein the first and second AC signals having a frequency between 100 and 200 kHz.

4. The apparatus of claim 1 , wherein the AC signal generator comprises a single signal source and a switch that distributes an output of the single signal source to either the first pair of electrodes or the second pair of electrodes.

5. The apparatus of claim 1 , wherein the AC signal generator comprises a first signal source operatively connected to the first pair of electrodes and a second signal source operatively connected to the second pair of electrodes.

6. The apparatus of claim 1 , wherein the first AC signal and the second AC signal are turned on at a rate that is slow relative to the reciprocal of the field frequency, and fast relative to the duration of the first output state.

7. The apparatus of claim 1 , wherein the first AC signal and the second AC signal are turned on at a rate that reaches 90% of the steady-state values between 1-5 ms.

8. The apparatus of claim 1 , wherein the periodic control signal is a square wave.

9. The apparatus of claim 2 , wherein the AC signal generator comprises a single signal source and a switch that distributes an output of the single signal source to either the first pair of electrodes or the second pair of electrodes.

10. The apparatus of claim 2 , wherein the AC signal generator comprises a first signal source operatively connected to the first pair of electrodes and a second signal source operatively connected to the second pair of electrodes.

11. The apparatus of claim 2 , wherein the first AC signal and the second AC signal are turned on at a rate that is slow relative to the reciprocal of the field frequency, and fast relative to the duration of the first output state.

12. The apparatus of claim 2 , wherein the first AC signal and the second AC signal are turned on at a rate that reaches 90% of the steady-state values between 1-5 ms.

13. The apparatus of claim 2 , wherein the periodic control signal is a square wave.

Assignments (18)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
SECURITY INTEREST Recorded Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 45278 0825 Recorded Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0335 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 50395/0398 Recorded Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
OMNIBUS CONFIRMATION OF ASSIGNMENT AGREEMENT Recorded May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 045278/0825 Recorded Apr 14, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052391/0549 →
RELEASE OF SECURITY INTEREST Recorded Apr 13, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052383/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
SECURITY INTEREST Recorded May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045284/0851 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045278/0825 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2018
From: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
To: NOVOCURE LIMITED
Reel/Frame 044858/0416 →
SECURITY INTEREST Recorded Feb 2, 2015
From: NOVOCURE LIMITED
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 034866/0402 →
CHANGE OF NAME Recorded Dec 29, 2014
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 034594/0061 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2014
From: PALTI, YORAM
To: STANDEN LTD.
Reel/Frame 034531/0375 →
RELEASE OF SECURITY INTEREST Recorded Dec 20, 2013
From: DEUTSCHE BANK TRUST COMPANY AMERICAS
To: NOVOCURE LIMITED
Reel/Frame 031866/0567 →
SECURITY AGREEMENT Recorded Feb 20, 2013
From: NOVOCURE LIMITED
To: DEUTSCHE BANK TRUST COMPANY AMERICAS
Reel/Frame 029845/0135 →